AstraZeneca PLC (AZN)
AstraZeneca Market Cap : 319.57B for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GSK Plc | 114.82B |
| Mereo BioPharma Group Plc | 49.34M |
| Regeneron Pharmaceuticals, Inc. | 78.97B |
| Biodexa Pharmaceuticals Plc | 14.15M |
| BioNTech SE | 23.41B |
Market Cap Related Metrics
| PE Ratio | 62.06 |
| PS Ratio | 10.80 |
| PEG Ratio | 1.356 |
| Price to Book Value | 6.482 |
| Price to Free Cash Flow | 70.77 |
| Price | 203.49 |
| Earnings Yield | 1.61% |
| PEGY Ratio | 1.311 |
| Operating PE Ratio | 46.65 |
| Normalized PE Ratio | 61.08 |